Technical Articles

FGF-R4/CD334蛋白 怎么用?受体特性、配体选择与结合能力验证全解(重组人FGF-R4/CD334蛋白 / FGF-R4/CD334靶点蛋白解读)
What Is FGF-R4/CD334: Receptor Properties, Ligand Choice and Binding Validation
发布时间 2026-10-15
FGF-R4 (CD334) is an FGF receptor tyrosine kinase whose ligand recognition is shaped by FGF19 and KLB. This article explains receptor characteristics, ligand selection and SPR/ELISA-based binding validation of recombinant human FGF-R4.
View details
  • Signaling Pathway
  • FGF-R4
  • CD334
  • FGFR4
  • FGF19
  • KLB
  • receptor
  • SPR
  • binding assay
  • UA020009
FGFR4:肝癌靶向治疗为何盯上这条选择性受体
FGFR4: Why Hepatocellular Carcinoma Targeting Focuses on This Selective Receptor
发布时间 2026-09-20
Among the four FGFR family members, FGFR4 alone resides in the liver and binds the KLB co-receptor. From an industry perspective, this article dissects the FGF19 axis, its association with hepatocellular carcinoma and the design logic of selective in
View details
  • Signaling Pathway
  • FGFR4
  • Hepatocellular carcinoma
  • FGF19
  • Selective inhibitor
  • Targeted therapy
  • UA011375
一扇需要两把钥匙的门:FGF19、FGFR4 与 KLB 的开门过程
A Door That Needs Two Keys: How FGF19, FGFR4 and KLB Open the Gate
发布时间 2026-09-20
The FGFR4 door opens only when both keys—FGF19 and KLB—are inserted at the same time. This article walks through the four-step assembly of the FGF19-FGFR4-KLB ternary complex and the full process of signal entry.
View details
  • Signaling Pathway
  • FGFR4
  • FGF19
  • Beta-Klotho
  • KLB
  • Ternary complex
  • Hepatocellular carcinoma
  • UA011375
Total 3
  • 1
Go to